Prot# PDX-019: An Open-label, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Pralatrexate in Relapsed/Refractory Lymphoma Patients with Mild, Moderate, and Severe Renal Impairment

Project: Research project

Project Details

StatusFinished
Effective start/end date9/22/109/22/13

Funding

  • Allos Therapeutics (PDX-019)